Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Other Non-Current Assets (2016 - 2026)

Gyre Therapeutics has reported Other Non-Current Assets over the past 15 years, most recently at $2.5 million for Q4 2025.

  • Quarterly Other Non-Current Assets fell 17.76% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 17.76% year-over-year, with the annual reading at $2.5 million for FY2025, 17.76% down from the prior year.
  • Other Non-Current Assets was $2.5 million for Q4 2025 at Gyre Therapeutics, down from $5.3 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $5.6 million in Q1 2025 and troughed at $168000.0 in Q2 2022.
  • The 5-year median for Other Non-Current Assets is $932000.0 (2021), against an average of $1.8 million.
  • Year-over-year, Other Non-Current Assets plummeted 85.63% in 2022 and then surged 1546.43% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $472000.0 in 2021, then surged by 619.07% to $3.4 million in 2022, then plummeted by 70.68% to $995000.0 in 2023, then surged by 204.52% to $3.0 million in 2024, then fell by 17.76% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Other Non-Current Assets are $2.5 million (Q4 2025), $5.3 million (Q3 2025), and $5.3 million (Q2 2025).